Liver disease in pregnancy

Published on 10/03/2015 by admin

Filed under Obstetrics & Gynecology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1370 times

Chapter 23 LIVER DISEASE IN PREGNANCY

The most common liver diseases during pregnancy are preeclampsia and viral hepatitis. Less common causes that are specific to pregnancy include intrahepatic cholestasis of pregnancy, acute fatty liver of pregnancy, Budd-Chiari syndrome, liver hematoma and rupture, and liver infarction.

In evaluating a patient with possible hepatic disease, liver cell damage is assessed by measurement of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), whereas hepatic synthetic function is assessed by measurement of albumin level and prothrombin time (PT). Cholestatic disease is assessed by measurement of levels of alkaline phosphatase and bilirubin.

Acute fatty liver of pregnancy usually occurs late in pregnancy and is a medical emergency. It often manifests with nausea and vomiting, abdominal pain, headache, jaundice, and altered mental status. Acute fatty liver of pregnancy is associated with ALT levels lower than 500 IU/L; in acute viral hepatitis, in comparison, levels are often higher than 1000 IU/L. In addition, acute fatty liver of pregnancy is associated with disseminated intravascular coagulation, renal failure, pancreatitis, and hypoglycemia.

Intrahepatic cholestasis of pregnancy usually manifests initially with pruritus, followed by the development of jaundice. It is associated with elevations in serum bile acids (at least three times the normal level), bilirubin (<5 mg/dL), cholesterol and triglyceride levels, and normal or mildly elevated transaminase levels.

Budd-Chiari syndrome is the occlusion of the hepatic venous system and usually occurs in women with an underlying thrombophilia. This syndrome can occur at any time in pregnancy, and patients usually present with abdominal pain and distension, which progresses to ascites.

Suggested Work-Up

ALT, AST, bilirubin, and alkaline phosphatase measurements To determine whether the liver disease is caused by hepatocyte damage or cholestasis
Serum bile acid measurements To evaluate for intrahepatic cholestasis of pregnancy
Urinalysis To evaluate for proteinuria
Complete blood cell count To evaluate for anemia and thrombocytopenia, which are associated with liver disease
Blood urea nitrogen (BUN) and creatinine measurement To evaluate for renal disease
Partial thromboplastin time (PTT), PT, and international normalized ratio (INR) To evaluate for coagulopathy
Albumin measurement To evaluate liver synthetic function
Serum electrolyte measurements To evaluate for electrolyte abnormalities
Serum blood glucose measurement To evaluate for hypo- or hyperglycemia

Additional Work-Up

Right upper quadrant ultrasonography To evaluate the liver and gallbladder
Test for hepatitis A immunoglobulin M antibodies To evaluate for acute hepatitis A infection
Test for hepatitis B surface antigen To evaluate for hepatitis B infection (usually performed as a routine part of prenatal screening)
Test for hepatitis B core antibody To evaluate for hepatitis B infection
Test for hepatitis C antibody To evaluate for hepatitis C infection
Twenty-four-hour urine test for total protein To evaluate for proteinuria (if preeclampsia is suspected)
Uric acid measurement Elevated level is associated with preeclampsia
Lactate dehydrogenase measurement Elevated level may be a sign of hemolysis associated with preeclampsia
Test for antimitochondrial antibody To evaluate for primary biliary cirrhosis
Test for antinuclear antibody (ANA) and smooth muscle antibody To evaluate for autoimmune hepatitis